Strafford will be offering a webinar entitled "Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges" on December 29, 2022 from 1:00 to 2:30 pm (EST). Adriana L. Burgy, Justin J. Hasford, and Thomas L. Irving of Finnegan Henderson Farabow Garrett & Dunner, and Angela Sebor of Tolmar will guide attendees on patenting drug formulations from drafting through patent prosecution and enforcement, examine lessons learned from the case law, and offer strategies to overcome the potential challenges. The webinar will review the following issues:
• What steps can counsel for patentees take during drafting to avoid written description and enablement problems and withstand invalidity/unpatentability challenges based on written description and enablement?
• What steps should patent counsel take to balance showing unpredictability for non-obviousness to fulfill the enablement and written description requirements?
• How to use means-plus-function claims for pharmaceutical formulations against ANDA filers and/or 505(b)(2) filers; and
• What factors does counsel need to keep in mind when litigating formulation claims?
The registration fee for the webcast is $347. Those interested in registering for the webinar, can do so here.
Comments